Cargando…

Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We aimed to evaluate the safety and efficacy of hydroxychloroquine (HCQ) added to standard care in patients with COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales:	Abd-Elsalam, Sherief, Esmail, Eslam Saber, Khalaf, Mai, Abdo, Ehab Fawzy, Medhat, Mohammed A., Abd El Ghafar, Mohamed Samir, Ahmed, Ossama Ashraf, Soliman, Shaimaa, Serangawy, Ghada N., Alboraie, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543820/ https://www.ncbi.nlm.nih.gov/pubmed/32828135 http://dx.doi.org/10.4269/ajtmh.20-0873

Ejemplares similares

Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Response to “Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy”
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Retraction Note to: Efficacy of favipiravir in COVID‑19 treatment: a multi‑center randomized study
por: Dabbous, Hany M., et al.
Publicado: (2021)

Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial
por: Abd-Elsalam, Sherief, et al.
Publicado: (2022)

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village
por: Ahmed, Ossama Ashraf, et al.
Publicado: (2018)

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure
por: Abo-amer, Yousry Esam-Eldin, et al.
Publicado: (2020)

Management of liver disease patients in different clinical situations during COVID-19 pandemic
por: Zaky, Samy, et al.
Publicado: (2021)

Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
por: Hanafy, Amr Shaaban, et al.
Publicado: (2020)

Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Clinical evaluation of pregnant women with SARS-COV2 pneumonia: a real-life study from Egypt
por: Zaky, Samy, et al.
Publicado: (2021)

Effect of COVID-19 on gastrointestinal endoscopy practice: a systematic review
por: Emara, Mohamed H., et al.
Publicado: (2022)

Clinical characteristics of human fascioliasis in Egypt
por: Ibrahim, Nagat, et al.
Publicado: (2023)

Endoscopic injection sclerotherapy versus N-Butyl-2 Cyanoacrylate injection in the management of actively bleeding esophageal varices: a randomized controlled trial
por: Elsebaey, Mohamed A., et al.
Publicado: (2019)

Pigtail Catheter: A Less Invasive Option for Pleural Drainage in Egyptian Patients with Recurrent Hepatic Hydrothorax
por: Sharaf-Eldin, Mohamed, et al.
Publicado: (2016)

Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study
por: Dawood, Reham M, et al.
Publicado: (2021)

Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Dabbous, Hany M., et al.
Publicado: (2021)

Comparative Evaluation of Colon Cancer Specific Antigen-2 Test and Chromocolonoscopy for Early Detection of Egyptian Patients with Colorectal Cancer
por: Elhossary, Marwa, et al.
Publicado: (2020)

Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Barriers for resuming endoscopy service in the context of COVID-19 pandemic: A multicenter survey from Egypt
por: Elshaarawy, Omar, et al.
Publicado: (2020)

IL-1α correlates with severity of hepatitis C virus-related liver diseases
por: Tawfik, Ahmed Khaled, et al.
Publicado: (2018)

Knowledge, Applicability, and Barriers of Telemedicine in Egypt: A National Survey
por: Alboraie, Mohamed, et al.
Publicado: (2021)

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial
por: El-Haggar, Sahar M, et al.
Publicado: (2022)

Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
por: Tawfik, Ahmed Khaled, et al.
Publicado: (2018)

Persistent Colonic Schistosomiasis among Symptomatic Rural Inhabitants in the Egyptian Nile Delta
por: Ahmed, Mohamed Hussien, et al.
Publicado: (2021)

Assessment of CXCL10 Before and After Narrow Band UVB Phototherapy in Non-Segmental Vitiligo Patients
por: Hussein, Sherief M., et al.
Publicado: (2022)

Sofosbuvir/Ledipasvir in Combination or Nitazoxanide Alone are Safe and Efficient Treatments for COVID-19 Infection: A Randomized Controlled Trial for Repurposing antivirals
por: Medhat, Mohamed A., et al.
Publicado: (2022)

Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study
por: Mansour, Loai, et al.
Publicado: (2018)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
por: Mohamed, Amal A, et al.
Publicado: (2022)

Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)

Helicobacter pylori infection and risk of salmonella infection
por: Salama, Rasha I., et al.
Publicado: (2019)

Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship
por: Hanafy, Amr Shaaban, et al.
Publicado: (2018)

Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity
por: Hammad, Reham, et al.
Publicado: (2021)

Phenotypic and genotypic detection of extended spectrum β-lactamases among Escherichia coli and Klebsiella pneumoniae isolates from type 2 diabetic patients with urinary tract infections
por: Elmi, Souad Youssouf Kani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f32t9ru54k59ak9gpgo0c6isn3